These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Frequency of anti-nuclear antibodies in multiple sclerosis. Barned S; Goodman AD; Mattson DH Neurology; 1995 Feb; 45(2):384-5. PubMed ID: 7854544 [TBL] [Abstract][Full Text] [Related]
8. The contribution of magnetic resonance imaging to the assessment of optic nerve and spinal cord involvement in multiple sclerosis. Moseley IF; Miller DH; Gass A J Neurol Neurosurg Psychiatry; 1998 May; 64 Suppl 1():S15-20. PubMed ID: 9647279 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988 [TBL] [Abstract][Full Text] [Related]
10. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714 [TBL] [Abstract][Full Text] [Related]
11. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Imai H; Nakano Y; Kiyosawa K; Tan EM Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118 [TBL] [Abstract][Full Text] [Related]
12. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610 [TBL] [Abstract][Full Text] [Related]
13. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. Fukazawa T; Kikuchi S; Sasaki H; Hamada K; Hamada T; Miyasaka K; Tashiro K J Neurol Sci; 1998 Jun; 158(2):209-14. PubMed ID: 9702693 [TBL] [Abstract][Full Text] [Related]
14. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245 [TBL] [Abstract][Full Text] [Related]
15. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies. Scott-Morgan L; Lloyd RS Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005 [TBL] [Abstract][Full Text] [Related]
16. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. de Andrés C; Guillem A; Rodríguez-Mahou M; López Longo FJ Acta Neurol Scand; 2001 Aug; 104(2):83-7. PubMed ID: 11493223 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence. Lee TK; Rothberger H Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735 [TBL] [Abstract][Full Text] [Related]
18. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845 [TBL] [Abstract][Full Text] [Related]
19. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Homburger HA; Cahen YD; Griffiths J; Jacob GL Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China. Yang Z; Ren Y; Liu D; Lin F; Liang Y APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]